An experimental Alzheimer’s drug might slow formation of the plaque that clogs the brains of people with the disease.
That’s the finding of new research for the drug called bapineuzumab (bap-ih-NOOZ-uh-mab),
However, researchers say it failed to stop mental decline, so it won’t help people who have dementia now.
But doctors say it might work if given earlier in the course of the disease, before memory loss has occurred.
In one study, some people on the drug had lower levels of a substance that forms the brain plaques than others who were given a dummy treatment.